The National Institute of Allergy and Infectious Diseases (NIAID) announced yesterday that it has awarded $2.5 million in grants to support research on bacteriophage therapy.
Higher viral loads of SARS-CoV-2, the virus that causes COVID-19, are associated with an increased risk of transmission, according to cohort study results from Catalonia, Spain, published yesterday in The Lancet Infectious Diseases,
A coalition of animal welfare, public health, environmental, and consumer organizations is speaking out against use of the One Health Certified (OHC) label on chicken and turkey products, claiming the standards behind the label don't protect against overuse of medically important antibiotics in food-producing animals.
A new study led by researchers with Pfizer shows a substantial burden of extraintestinal invasive Escherichia coli infections (IEIs) in the United States, with increasing resistance to extended-spectrum cephalosporins.
A multistate analysis of hospitalized COVID-19 patients in the American Journal of Epidemiology yesterday found that 12.6% of patients died, with blacks especially hard hit.
The Centers for Disease Control and Prevention (CDC) ended two separate Escherichia coli O157:H7 investigations on Dec 18. Neither of the outbreaks had a definitive source, although one triggered a food recall on a single brand of romaine lettuce.
Chronic wasting disease (CWD), a fatal neurologic prion disease that affects members of the deer family, was detected in two cervids in Montana and Virginia. In 2019, 144 cases of CWD were reported in Montana and 1 case was reported in Virginia.
An antibiotic stewardship program (ASP) intervention led by ambulatory care pharmacists was associated with improvements in guideline-concordant antibiotic prescribing in a family medicine residency clinic, researchers reported today in Infection Control and Hospital Epidemiology.
A study of community-level antibiotic use in patients in four low- and middle-income countries (LMICs) found frequent use of broad-spectrum antibiotics considered at risk of becoming ineffective owing to rising antibiotic resistance, an international team of researchers reported today in Clinical Microbiology and Infection.
Yesterday the Centers for Disease Control and Prevention (CDC) reported two separate Escherichia coli O157:H7 outbreaks in the United States. Neither has an identified source, and one has already proved deadly.
